Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
xintela
-
search results
If you're not happy with the results, please do another search
Targinta’s CEO: “Strong interest in ADCs in 2023”
22 January, 2024
CombiGene’s new CEO talks about his visions for the company
4 September, 2023
Xintela highlights the unique properties of XSTEM
30 May, 2023
Xintela initiates last dose level in knee osteoarthritis study
2 May, 2023
Xintela’s chairman about the company’s journey
30 March, 2023
Targinta positions itself in the ADC field
22 March, 2023
BioStock Investor Meeting starts today at 10.00
16 March, 2023
Xintela’s strategy for 2023
17 February, 2023
BioStock Investor Meeting 2023
10 February, 2023
VILDA – new network for female leaders in life science
16 January, 2023
The value of patent protection in life science
14 December, 2022
Watch the BioStock Life Science Fall Summit!
8 December, 2022
Flerie Invest bets big on life science
21 October, 2022
CombiGene’s new COO wants to be involved in building a large...
30 September, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
Top 5 life science stocks – first half of 2022
1 July, 2022
New management at Cyxone
22 June, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
Targinta takes lead in the ADC field in the Nordics
23 May, 2022
Targinta’s CEO comments on preclinical data in TNBC and the spin-out
13 April, 2022
Xintela’s CEO sees potential in difficult-to-heal wounds
12 April, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
Xintela presents the plans for 2022 in its Q4 report
4 March, 2022
Xintela advances to clinical phase in OA and difficult-to-heal wounds in...
19 January, 2022
Xintela approaches the market with EQSTEM
3 November, 2021
Targinta’s CEO on TARG10 and the spin-off
22 October, 2021
BioStock Studio: Xintela expands to venous leg ulcers
12 October, 2021
Targinta’s new CEO has started
3 September, 2021
Xintela signs agreement with CRO for phase I/II study
12 August, 2021
Bauerfeind AG loan signals confidence in Xintela
6 July, 2021
Xintela advances on several fronts
6 July, 2021
BioStock studio: Xintela looks ahead
6 July, 2021
Xintela’s cancer project granted 2 million SEK by Vinnova
5 July, 2021
Xintela reports promising results in Covid-19 project
3 July, 2021
Xintela’s CEO comments on the positive patent notice
3 July, 2021
Xintela’s CEO on successful studies and approved GMP facility
27 May, 2021
New CEO for Xintela’s subsidiary Targinta
11 May, 2021
Xintela’s CEO on recent successes
30 March, 2021
Xintela is preparing for progress in 2021
29 January, 2021
Status report Xintela – Integrins marking the future
30 October, 2020
BLSS 2019 videos: Innovation takes centre stage in the second round...
31 October, 2019
